Compound Detail
CHEMBL4469414
LUVIXASERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Cc1cc(-c2cnn3c(NC[C@H]4C[C@@](C)(O)C4)cc(Oc4cccnc4)nc23)ccc1C(=O)NC1CC1
Basic Information
| ChEMBL ID | CHEMBL4469414 |
| Name | LUVIXASERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | PMQUGSPFUBGJCZ-CHOKWEPUSA-N |
5
Targets
12
Activities
2
Assay Types
8
PK Parameters
17
Publications
3
Known Names
3
Indications
Molecular Properties
498.6
MW (Da)
4.36
ALogP
8
HBA
3
HBD
113.7
PSA (Ų)
0.33
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Neoplasms Neoplasms Breast Neoplasms
Activity Summary
IC50 11 meas. best 9.22
Ki 1 meas. best 10.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dual specificity protein kinase TTK CHEMBL3983 | Ki | 10.0 | 10.0 | 0.1 | 1 |
| Dual specificity protein kinase TTK CHEMBL3983 | IC50 | 9.22 | 8.585 | 0.6 | 6 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 6.29 | 5.57 | 510.0 | 2 |
| HT-29 CHEMBL384 | IC50 | 6.25 | 6.25 | 557.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 4.89 | 4.89 | 13000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 7500.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 3400.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 25000.0 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 14.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 4.9 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 5014.14 | nM | Mus musculus |
| F | 53.0 | % | Rattus norvegicus |
| F | 114.0 | % | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine